NENC Medicines Subcommittee and NTAG decisions – April 2024

The decisions made at the NENC Medicines Subcommittee April 2024 meeting can now be found at: https://ntag.nhs.uk/meetings/decision-summaries/

This includes the recommendations made by NTAG at its March 2024 meeting and NICE Technology appraisals from the 1st December 2023 to 31st January 2024.

The following guidelines/position statements were approved and can be found at:

The following guidelines/position statements were archived/deleted from the NTAG website:

  • NENC Patient Specific Factors to Consider When Choosing a DOAC in NVAF

New Consultation: Formulary decisions March 2024

The North East and North Cumbria (NENC) Medicines Committee are seeking NENC system-wide views on adoption of the draft decisions made by the NENC formulary group at their meeting in March 2024.

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC.

This consultation will run for four weeks and closes at 5pm on Tuesday 7th May 2024. Take part by visiting the consultations page.


Medicines Committee decision – NICE TA953, TA956 – March/April 2024

The decision made with regard to these NICE 30 day TAs can now be found at: https://ntag.nhs.uk/meetings/decision-summaries/

  • NICE TA 953: Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema
  • NICE TA956: Etrasimod for treating moderately to severely active ulcerative colitis in people aged 16 and over

New Consultation: Formulary Amendments March 2024

North East and North Cumbria (NENC) Medicines Committee are seeking NENC system-wide views on adoption of the proposed formulary amendments in a new consultation, covering NICE Technology Appraisals and other relevant guidance and alerts published in March 2024.

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC. These consultations will run for four weeks and close at 5pm on Monday 6th May 2024. Take part by visiting the consultations page.


New Consultation: Formulary Amendments February 2024

North East and North Cumbria (NENC) Medicines Committee are seeking NENC system-wide views on adoption of the proposed formulary amendments in a new consultation, covering NICE Technology Appraisals and other relevant guidance and alerts published in February 2024.

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC. These consultations will run for four weeks and close at 5pm on Wednesday 17th April 2024. Take part by visiting the consultations page.


New Consultation: Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema. 30 day TA

The North East and North Cumbria (NENC) Medicines Committee are seeking system-wide views on adoption of the proposed TA953: Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema, in the attached consultation document.

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC.

This consultation will run for two weeks and closes at 5pm on Wednesday 27th March 2024. Take part by visiting the consultations page.


New Consultation: NENC SCG Ketamine for Pain in Palliative Care for patients within adult services

Following the March 2024 NENC Medicines Guidelines Group we now seek comments from across the NENC ICB on this new NENC wide guideline which has been developed to replace the previous shared care guidelines for ketamine in palliative care that currently exist in North of Tyne, Gateshead and North Cumbria.

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC.

This consultation will run for four weeks and closes at 5pm on Wednesday 10th April 2024.

Take part by visiting the consultations page.


New Consultation: NENC SCG Azathioprine/6-Mercaptopurine in adults

Following the March 2024 NENC Medicines Guidelines Group we now seek comments from across the NENC ICB on this new NENC wide guideline which has been developed to replace the previous shared care guidelines for Azathioprine/6-Mercaptopurine which currently exist across the North East and North Cumbria. 

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC.

This consultation will run for four weeks and closes at 5pm on Wednesday 10th April 2024.

Take part by visiting the consultations page.


New Consultation: NENC Hydroxychloroquine in adults shared care guidance

Following the March 2024 NENC Medicines Guidelines Group we now seek comments from across the NENC ICB on this new NENC wide guideline which has been developed to replace the previous shared care guidelines for hydroxychloroquine which currently exist across the North East and North Cumbria.

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC.

This consultation will run for four weeks and closes at 5pm on Wednesday 10th April 2024.

Take part by visiting the consultations page.


New Consultation: NENC Adult Headache guideline

Following the March 2024 NENC Medicines Guidelines Group we now seek comments from across the NENC ICB on this updated NENC wide guideline which has been developed to replace the previous version by the Regional Headache MDT Group

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC.

This consultation will run for four weeks and closes at 5pm on Wednesday 10th April 2024.

Take part by visiting the consultations page.